
Roche’s momentum in digital pathology continues with FDA clearance on its high-volume slide scanner
TUCSON, Ariz., Jan. 9, 2025 /PRNewswire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its whole slide imaging system, Roche Digital Pathology Dx, has received an additional 510(k) clearance from the United States Food and Drug Administration (FDA).